Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Cancer Treatment Reports
|
March 1, 1981
Phase II evaluation of cycloleucine in the treatment of patients with disseminated sarcomas
L H Baker, R J Fraile, M K Samson, et al.
American Journal of Clinical Oncology
|
December 1, 1982
Phase II trial of methyl-GAG (NSC-32946) in squamous cell and adenocarcinoma of the lung
M K Samson, L H Baker, G Cummings, et al.
Cancer Treatment Reports
|
September 1, 1976
Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma
M K Samson, L H Baker, R M Izbicki, et al.
Cancer Clinical Trials
|
January 1, 1980
Phase I-II clinical trial of gallium nitrate (NSC-15200)
M K Samson, R J Fraile, L H Baker, et al.
American Journal of Clinical Oncology
|
April 1, 1985
Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trial
M K Samson, C D Haas, L H Baker, et al.
European Journal of Cancer
|
December 1, 1978
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary
M K Samson, L H Baker, R W Talley, et al.
Cancer Treatment Reports
|
November 1, 1979
Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung
R J Fraile, M K Samson, L H Baker, et al.
American Journal of Clinical Oncology
|
August 1, 1984
Phase II clinical evaluation of AZQ in adenocarcinoma of the lung
D A Decker, M K Samson, C D Haas, et al.
Cancer
|
November 1, 1976
Alterations in plasma sialyltransferase associated with successful chemotherapy of a disseminated tumor. Case report
D Kessel, M K Samson, P Shah, et al.
Cancer Clinical Trials
|
January 1, 1979
Use of VM-26 as a single agent in the treatment of renal carcinoma
E A Hire, M K Samson, R J Fraile, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Cancer Treatment Reports
|
March 1, 1981
Phase II evaluation of cycloleucine in the treatment of patients with disseminated sarcomas
L H Baker, R J Fraile, M K Samson, et al.
American Journal of Clinical Oncology
|
December 1, 1982
Phase II trial of methyl-GAG (NSC-32946) in squamous cell and adenocarcinoma of the lung
M K Samson, L H Baker, G Cummings, et al.
Cancer Treatment Reports
|
September 1, 1976
Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma
M K Samson, L H Baker, R M Izbicki, et al.
Cancer Clinical Trials
|
January 1, 1980
Phase I-II clinical trial of gallium nitrate (NSC-15200)
M K Samson, R J Fraile, L H Baker, et al.
American Journal of Clinical Oncology
|
April 1, 1985
Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trial
M K Samson, C D Haas, L H Baker, et al.
European Journal of Cancer
|
December 1, 1978
VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary
M K Samson, L H Baker, R W Talley, et al.
Cancer Treatment Reports
|
November 1, 1979
Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung
R J Fraile, M K Samson, L H Baker, et al.
American Journal of Clinical Oncology
|
August 1, 1984
Phase II clinical evaluation of AZQ in adenocarcinoma of the lung
D A Decker, M K Samson, C D Haas, et al.
Cancer
|
November 1, 1976
Alterations in plasma sialyltransferase associated with successful chemotherapy of a disseminated tumor. Case report
D Kessel, M K Samson, P Shah, et al.
Cancer Clinical Trials
|
January 1, 1979
Use of VM-26 as a single agent in the treatment of renal carcinoma
E A Hire, M K Samson, R J Fraile, et al.
Page
of 6